Autophagy Determines Efficiency of Liver-Directed Gene Therapy With Adeno-Associated Viral Vectors

被引:37
|
作者
Hoesel, Marianna [1 ,2 ]
Huber, Anke [1 ,2 ]
Bohlen, Susanne [3 ]
Lucifora, Julie [4 ]
Ronzitti, Giuseppe [5 ,6 ]
Puzzo, Francesco [5 ,6 ]
Boisgerault, Florence [5 ,6 ]
Hacker, Ulrich T. [7 ]
Kwanten, Wilhelmus J. [8 ]
Kloeting, Nora [9 ]
Blueher, Matthias [10 ]
Gluschko, Alexander [1 ,3 ]
Schramm, Michael [1 ,3 ]
Utermoehlen, Olaf [1 ,3 ]
Bloch, Wilhelm [11 ]
Mingozzi, Federico [5 ,6 ,12 ]
Krut, Oleg [3 ]
Buening, Hildegard [1 ,2 ,13 ]
机构
[1] Univ Cologne, CMMC, Cologne, Germany
[2] German Ctr Infect Res DZIF, Partner Sites Bonn Cologne & Hannover Braunschwei, Braunschweig, Germany
[3] Univ Cologne, Inst Med Microbiol Immunol & Hyg, Cologne, Germany
[4] Univ Lyon, CRCL, INSERM, U1052, Lyon, France
[5] Genethon, Evry, France
[6] INSERM, U951, Evry, France
[7] Univ Med Leipzig, UCCL, Leipzig, Germany
[8] Univ Antwerp, LEMP, Antwerp, Belgium
[9] Univ Leipzig, IFB Adipos Dis, Leipzig, Germany
[10] Univ Leipzig, Dept Med, Leipzig, Germany
[11] German Sport Univ Cologne, Dept Mol & Cellular Sport Med, Cologne, Germany
[12] Univ Paris 06, Paris, France
[13] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany
基金
欧洲研究理事会;
关键词
HEPATIC LIPID-METABOLISM; MAMMALIAN TARGET; HEMOPHILIA-B; IN-VITRO; VIRUS; RAPAMYCIN; MTOR; TRANSDUCTION; DISEASES; CANCER;
D O I
10.1002/hep.29176
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Use of adeno-associated viral (AAV) vectors for liver-directed gene therapy has shown considerable success, particularly in patients with severe hemophilia B. However, the high vector doses required to reach therapeutic levels of transgene expression caused liver inflammation in some patients that selectively destroyed transduced hepatocytes. We hypothesized that such detrimental immune responses can be avoided by enhancing the efficacy of AAV vectors in hepatocytes. Because autophagy is a key liver response to environmental stresses, we characterized the impact of hepatic autophagy on AAV infection. We found that AAV induced mammalian target of rapamycin (mTOR)-dependent autophagy in human hepatocytes. This cell response was critically required for efficient transduction because under conditions of impaired autophagy (pharmacological inhibition, small interfering RNA knockdown of autophagic proteins, or suppression by food intake), recombinant AAV-mediated transgene expression was markedly reduced, both in vitro and in vivo. Taking advantage of this dependence, we employed pharmacological inducers of autophagy to increase the level of autophagy. This resulted in greatly improved transduction efficiency of AAV vectors in human and mouse hepatocytes independent of the transgene, driving promoter, or AAV serotype and was subsequently confirmed in vivo. Specifically, short-term treatment with a single dose of torin 1 significantly increased vector-mediated hepatic expression of erythropoietin in C57BL/6 mice. Similarly, coadministration of rapamycin with AAV vectors resulted in markedly enhanced expression of human acid-alpha-glucosidase in nonhuman primates. Conclusion: We identified autophagy as a pivotal cell response determining the efficiency of AAVs intracellular processing in hepatocytes and thus the outcome of liver-directed gene therapy using AAV vectors and showed in a proof-of-principle study how this virus-host interaction can be employed to enhance efficacy of this vector system.
引用
收藏
页码:252 / 265
页数:14
相关论文
共 50 条
  • [31] Safety of adeno-associated viral vectors
    Lin, Shih-Wen
    Ertl, Hildegund C. J.
    FUTURE VIROLOGY, 2008, 3 (05) : 491 - 503
  • [32] Adeno-associated viral vectors as gene delivery vehicles (review)
    Carter, PJ
    Samulski, RJ
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2000, 6 (01) : 17 - 27
  • [33] Gene delivery to the eye using adeno-associated viral vectors
    Martin, KRG
    Klein, RL
    Quigley, HA
    METHODS, 2002, 28 (02) : 267 - 275
  • [34] Directed Evolution of Adeno-Associated Virus Vectors in Human Cardiomyocytes for Cardiac Gene Therapy
    Kok, Cindy Y.
    Alexander, Ian
    Lisowski, Leszek
    Kizana, Eddy
    HEART LUNG AND CIRCULATION, 2018, 27 (11): : 1270 - 1273
  • [35] Adeno-associated viral vectors for clinical gene transfer studies
    Snyder, RO
    Francis, J
    CURRENT GENE THERAPY, 2005, 5 (03) : 311 - 321
  • [36] Advances in Recombinant Adeno-Associated Viral Vectors for Gene Delivery
    Petrs-Silva, Hilda
    Linden, Rafael
    CURRENT GENE THERAPY, 2013, 13 (05) : 335 - 345
  • [37] Recombinant adeno-associated virus vectors for gene therapy
    Conlon, TJ
    Flotte, TR
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (07) : 1093 - 1101
  • [38] Adenovirus and adeno-associated virus as vectors for gene therapy
    Berns, KI
    Giraud, C
    DNA VACCINES: A NEW ERA IN VACCINOLOGY, 1995, 772 : 95 - 104
  • [39] Engineering adeno-associated virus vectors for gene therapy
    Li, Chengwen
    Samulski, R. Jude
    NATURE REVIEWS GENETICS, 2020, 21 (04) : 255 - 272
  • [40] Gene Therapy Using Adeno-Associated Virus Vectors
    Daya, Shyam
    Berns, Kenneth I.
    CLINICAL MICROBIOLOGY REVIEWS, 2008, 21 (04) : 583 - 593